-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: How will Trump handle the CDC and ACIP?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: The intersection of ‘Apprentice’ and the No Surprises Act
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Spring break is here, and our family is road tripping to...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: Epic says it has uncovered rot in patient record sharing. Will HHS act?
In a recent court filing, electronic health records giant Epic Systems proved one of health care providers’ worst fears: Companies are posing as providers to gain...
-
AI & Machine Learning in Biotechnology3 weeks agoAll the highlights from STAT’s Breakthrough Summit East
Good morning and happy Friday. I’m off today, but I’ll talk to you next week. Highlights from yesterday’s summit For me, the top moment from yesterday’s...
-
AI & Machine Learning in Biotechnology3 weeks agoDrug development is booming in China. Should the U.S. view it as a threat or an opportunity?
If the U.S. wants to hold on to its title as the world’s top biotech innovator, it might want to take a page out of China’s...
-
AI & Machine Learning in Biotechnology3 weeks agoIndependent autism committee kicks off efforts to counter RFK Jr., influence Congress
WASHINGTON — Autism scientists and advocates met Thursday to develop an agenda for autism research, the first gathering of a group that hopes to command the...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Trump’s Medicare director seeks to rein in expectations for TrumpRx
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Democrats prepare for health care overhaul
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Eli Lilly’s ‘triple-G’ shows potency, raises concerns
Regulators are trying to push drug development into a post-animal testing era. Meanwhile, a Jennifer Doudna-founded company is edging toward successful CAR-T therapy done in vivo, and...
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
